CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair–Deficient/Microsatellite Instability–High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer
Jwa Hoon Kim, Sun Young Kim, Ji Yeon Baek, Yong Jun Cha, Joong Bae Ahn, Han Sang Kim, Keun-Wook Lee, Ji-Won Kim, Tae-You Kim, Won Jin Chang, Joon Oh Park, Jihun Kim, Jeong Eun Kim, Yong Sang Hong, Yeul Hong Kim, Tae Won Kim
Cancer Research and Treatment. 2020;52(4):1135-1144.   Published online 2020 April 24    DOI: https://doi.org/10.4143/crt.2020.218

Excel Download

The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer
ESMO Open. 2021;6(3):100145   Crossref logo
Link1 Link2

Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer
European Journal of Cancer. 2021;144:9-16   Crossref logo
Link1 Link2

Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer
Journal of Clinical Medicine. 2019;8(4):558   Crossref logo
Link1

Microsatellite Instability and Mismatch Repair Genes in Colorectal Cancer: Useful Tools for Managing Patients and Counseling Their Relatives
Clinical Colorectal Cancer. 2010;9(4):193-194   Crossref logo
Link1 Link2

P-275 First-line pembrolizumab versus investigator-choice chemotherapy for mismatch repair–deficient or microsatellite instability–high metastatic colorectal carcinoma: randomized, phase 3 KEYNOTE-177 study
Annals of Oncology. 2016;27:ii80   Crossref logo
Link1 Link2 Link3

Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer
Cancer. 2018;125(2):278-289   Crossref logo
Link1 Link2

Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer
Journal of Medical Economics. 2021;24(1):675-688   Crossref logo
Link1

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
The Lancet Oncology. 2017;18(9):1182-1191   Crossref logo
Link1 Link2

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency
Cancers. 2021;13(5):1149   Crossref logo
Link1

Microsatellite instability, mismatch repair deficiency, and colorectal cancer
Surgery. 2001;130(1):17-20   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.